Feedback Share Discussion Threads

[ducatiman] 06/12/2020 11:39

Of course the India mission is good news Ged. So is the RS buy, so are the multiple new appointments. The market, however, needs the proof by way of sales/contracts that this is indeed a completely new company.
When/if they start coming the market will seriously rerate us. Let’s just hope this is forthcoming.

[ducatiman] 04/12/2020 19:15

Their negativity is well placed currently LR2 and we would do well to take it on board. As I have posted above I would be a seller currently if it were not for the RS buys.
They say this is a completely different company (in the results) than a year ago. However to date nothing seems different to me.
Still supporting nice lifestyles with £40k bonus to the CEO BUT nominal sales.
Same train of jam tomorrow RNS.
Same if not worse cashburn.
Same rhetoric when the begging bowl goes out on a regular basis.
Hopefully they will pull a rabbit out of the hat soon because as a poster has posted above the market will not tolerate another cash call.

[lr2] 04/12/2020 17:46

Short fuse Duc. If I'm going to spend time on these boards I'm going to try and read as much good stuff as possible which means filtering those who swear and negativistic irregulars. Just my way after 18 years on Advfn.

[davwal] 04/12/2020 17:20

Fingers in the ears and humming works too, I gather...

[brasso3] 04/12/2020 17:19

You guys got me excited with 20 posts! Still waiting (patiently)...

[ducatiman] 04/12/2020 17:06

Nobody has posted anything today that would make me filter them. In fact some of the negative posts are correct in what they are saying.

[coldspring] 04/12/2020 16:44

You end up in an echo chamber then LR2 not healthy for someone who seeks balance as I do.

[lr2] 04/12/2020 16:42

All comments welcome for sure but I reserve the right to filter if required.

Had to do a fair bit of that over on DIS recently... then again, I do have around 2,300 names on my filter list.

[davwal] 04/12/2020 16:40

I am not a regular poster nor a current holder, but am interested. My earlier ‘negative̵7; post was purely an observation with absolutely no ulterior motive. I’d buy right now if there was any sign of a health organisation taking Bleepa for actual money. I hope one does. Otherwise, I’d have thought a better-funded competitor might have made an offer for Feedback if Bleepa looked a game changer. But that’s just another observation...

[ged5] 04/12/2020 16:29

No LR2. Just a google search. I've used their info book a few times.

"Could be they want a lower price at which to buy." I do.

That gap is tantalisingly near to being closed.

All comments welcome here as far as I am concerned.

[monkey puzzle] 04/12/2020 16:17

Why is there always an ulterior motive assumed for anyone commenting on here who isn't praising the company? All that hype for the CE mark and £5m raised on the back of it, since then...zzzzzzzzzzzzzzzz

[lr2] 04/12/2020 16:12

You've got CIA contacts Ged? Nice one.

Can't see much of a problem here. Rory won't have bumped his holding up to 9.8 mil shares on a whim just 5 weeks ago. All that is needed is patience.

We've had a number of posters on here today sowing doubt and discord. They aren't regulars either. So, why have they all gone negative on the company today? Could be they want a lower price at which to buy. Certainly not a flood of selling from them at the moment.

[monkey puzzle] 04/12/2020 16:12

Or is that too hard?

[ged5] 04/12/2020 16:03

Correct Monkey Puzzle. Disappointing there hasn't been a direct or indirect sale although there have been developments of the product.

"Proceeds of the Placing and the Open Offer will be used to develop the Company's flagship product, Bleepa®, an innovative app based on Feedback's Cadran technology, which allows medical staff to securely view and discuss high quality medical grade images on mobile devices. Funds will be applied to:

o Direct sales - engaging and converting NHS trusts to paying customers of Bleepa®

o Indirect sales - develop growth opportunities and 'go to market' strategies with key strategic partners

o Product development - extend and develop the functionality of Bleepa®, including for non-healthcare applications

o Territory expansion - to explore opportunities for international expansion, via direct and indirect sales

[ged5] 04/12/2020 15:58

Thanks LR2.

Some countries in the Middle East where they know about Bleepa have different Fiscal years. UAE and Saudi Arabia for example.

[monkey puzzle] 04/12/2020 15:50

I thought the £5m they raised was for marketing etc, not day to day business expenses?

[lr2] 04/12/2020 15:49

This is not the time of year to hear about new hospital expenditure. Budgets will be drawn up for the next financial year. We may hear of contracts beforehand but most will not start until next April. NHSx funding is the exception of course.

[ged5] 04/12/2020 15:37

Interesting comments about cash three months after the results. There should be about 3.5M if they are spending at the same rate. They're definitely going to need contracts otherwise the cash will run out in twelve months.

I also understand the frustration about lack of contracts.

There has been only one contract that was tied in to the Cadran renewal at Papworth. The trial at Oldham has been a success imo.

Not the news some wanted (I still think it will be next quarter) but today's news is about further exposure in a different market. I think today's news is significant.

From today's RNS:-

"The Department for International Trade (DIT) helps businesses export and grow into global markets. We also help overseas companies locate and grow in the UK. Our services are provided in over 100 markets throughout the world. We are passionate about what we do. That's why we constantly review our services in light of customer feedback and the impact they offer, which means they'll vary from time to time."

[hodhasharon] 04/12/2020 14:35

Feedback Medical Ltd
Feedback Medical Ltd
334 followers
13m • Edited • 13 minutes ago

We’re pleased to announce that Bleepa has been selected for Department for International Trade (DIT)'s India Healthcare Virtual Mission! The mission selects leading British #healthcare innovators working in artificial intelligence, digital health, smart diagnostics, and home-care technology. For both a COVID-19 and post-COVID world.

Innovation in healthcare delivery is a key priority for healthcare providers in India. The event offers us the chance to interact with key stakeholders and influencers from the Indian healthcare industry. This includes high-profile speakers from reputed organisations on key issues and opportunities in the industry, from both the UK and India. Find out more #healthtech #digitalhealth #healthinnovation

Jaslok Hospital & Research Centre Kamineni Hospitals Columbia Asia Hospital Rainbow Children's Hospitals Piramal Swasthya MIOT International Zydus Hospitals Wockhardt Hospitals Ltd Medanta Cytecare Cancer Hospitals Yashoda Hospitals Sakra World Hospital Shalby Limited Lifeline Children's Hospital HealthCare Global Aster DM Healthcare MIOT International

[monkey puzzle] 04/12/2020 14:32

Where's the £5m gone?

[sonie01] 04/12/2020 14:11

I think we should all be ringing their brokers and asking just WTF is going off